The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1606-1609

  Hingley, Susan T ^a   Leparc Goffart, Isabelle ^b,d   Weiss, Susan R ^b,c  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIA CELL; LIVER CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNCYTIUM; VIRUS CELL INTERACTION;

EID: 0031931227     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1606-1609.1998     Document Type: Article

References (25)

1. Bos, E. C. W., L. Heijnen, W. Luytjes, and W. J. M. Spaan. 1996. Mutational analysis of the murine coronavirus spike protein: effect on cell to cell fusion. Virology 214:453-463.
2. Cavanagh, D. 1995. The coronavirus surface glycoprotein, p. 73-113. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
3. Fleming, J. O., M. D. Trousdale, F. A. K. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869-875.
4. Frana, M. F., J. N. Behnke, L. S. Sturman, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:912-920.
5. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
6. Gallagher, T. M., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 64:731-741.
7. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
8. Gombold, J. L., and S. R. Weiss. 1992. Mouse hepatitis virus A59 increases steady state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb. Pathog. 13:493-505.
9. Gotoh, B., Y. Ohnishi, N. M. Inocencio, E. Esaki, K. Nakayama, P. J. Barr, G. Thomas, and Y. Nagai. 1992. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 66:6391-6397.
10. Hingley, S. T., J. L. Gombold, E. Lavi, and S. R. Weiss. 1994. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 200:1-10.
11. Hingley, S. T., J. L. Gombold, E. Lavi, and S. R. Weiss. 1995. Hepatitis mutants of mouse hepatitis virus strain A59. Adv. Exp. Med. Biol. 380:577-582.
12. Joseph, J., R. Kim, K. Siebert, F. D. Lublin, C. Offenbach, and R. L. Knobler. 1995. Organ specific endothelial cell heterogeneity influences differential replication and cytopathogenicity of MHV-3 and MHV-4. Adv. Exp. Med. Biol. 380:43-50.
13. Kreamer, B. L., J. L. Staecker, G. L. Sawada, G. L. Sattler, M. T. S. Hsia, and H. C. Pitot. 1986. Use of low speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro Cell. Dev. Biol. 22:201-211.
14. Lavi, E., P. S. Fishman, M. K. Highkin, and S. R. Weiss. 1988. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Invest. 58:31-36.
15. Lavi, E., E. M. Murray, S. Makino, S. A. Stohlman, M. M. C. Lai, and S. R. Weiss. 1990. Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by rihonucleic acid-ribonucleic acid recombination. Lab. Invest. 62:570-578.
16. Lavi, E., A. Suzumura, M. Hirayama, M. K. Highkin, D. M. Dambach, D. H. Silberberg, and S. R. Weiss. 1987. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb. Pathog. 3:79-86.
17. Luytjes, W., L. Sturman, P. J. Bredenbeck, J. Charite, B. A. M. van der Zeijst, M. C. Horzinek, and W. J. M. Spaan. 1987. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161:479-487.
18. Martin, J. P., W. Chen, F. Koehren, and C. A. Pereira. 1994. The virulence of mouse hepatitis virus 3, as evidenced by permissivity of cultured hepatic cells toward escape mutants. Res. Virol. 145:297-302.
19. Martin, J. P., W. Chen, G. Obert, and F. Koehren. 1990. Characterization of attenuated mutants of MHV3: importance of the E2 protein in organ tropism and infection of isolated liver cells. Adv. Exp. Med. Biol. 276:403-410.
20. Ohnishi, Y., T. Shioda, K. Nakayama, S. Iwata, B. Gotoh, M. Hamaguchi, and Y. Nagai. 1994. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type I. J. Virol. 68:4075-4079.
21. Schmidt, I., M. Skinner, and S. Siddell. 1987. Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J. Gen. Virol. 68:47-56.
22. Seglin, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
23. Spaan, W. J. M., D. Cavanagh, and M. C. Horzinek. 1988. Coronaviruses. Structure and genome expression. J. Gen. Virol. 69:2939-2952.
24. Stauber, R., M. Pfleiderer, and S. G. Siddell. 1993. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for infectivity. J. Gen. Virol. 74:183-191.
25. Taguchi, F., T. Ikeda, and H. Shida. 1992. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73:1065-1072.